
NLA Resources
6 Resources
The National Lipid Association is your destination for the science of lipid medicine. Now, everything we know is in one place.
6 Available Resources
This document aims to provide practical guidance on testing and management of Lp(a) for primary and secondary ASCVD risk management.
On September 4, 2026, Novartis announced the topline results of its phase 3 Lp(a)HORIZON trial. Novartis shared that while pelacarsen…
It is well-established that, compared to men, post-menopausal women enjoy a degree of protection against atherosclerotic cardiovascular disease (ASCVD).1 The…

Join the NLA
Become A Member
When you become a member of the NLA, you become part of a collegial multidisciplinary group of leaders dedicated to improving lipid and cardiometabolic health.
